Correlation Between Bionano Genomics and Utah Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bionano Genomics and Utah Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bionano Genomics and Utah Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bionano Genomics and Utah Medical Products, you can compare the effects of market volatilities on Bionano Genomics and Utah Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bionano Genomics with a short position of Utah Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bionano Genomics and Utah Medical.

Diversification Opportunities for Bionano Genomics and Utah Medical

0.39
  Correlation Coefficient

Weak diversification

The 3 months correlation between Bionano and Utah is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Bionano Genomics and Utah Medical Products in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Utah Medical Products and Bionano Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bionano Genomics are associated (or correlated) with Utah Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Utah Medical Products has no effect on the direction of Bionano Genomics i.e., Bionano Genomics and Utah Medical go up and down completely randomly.

Pair Corralation between Bionano Genomics and Utah Medical

Given the investment horizon of 90 days Bionano Genomics is expected to under-perform the Utah Medical. In addition to that, Bionano Genomics is 4.14 times more volatile than Utah Medical Products. It trades about -0.17 of its total potential returns per unit of risk. Utah Medical Products is currently generating about -0.02 per unit of volatility. If you would invest  6,769  in Utah Medical Products on August 29, 2024 and sell it today you would lose (254.00) from holding Utah Medical Products or give up 3.75% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Bionano Genomics  vs.  Utah Medical Products

 Performance 
       Timeline  
Bionano Genomics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bionano Genomics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Utah Medical Products 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Utah Medical Products has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Utah Medical is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Bionano Genomics and Utah Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bionano Genomics and Utah Medical

The main advantage of trading using opposite Bionano Genomics and Utah Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bionano Genomics position performs unexpectedly, Utah Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Utah Medical will offset losses from the drop in Utah Medical's long position.
The idea behind Bionano Genomics and Utah Medical Products pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins